Janux Therapeutics Inc (JANX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Janux Therapeutics Inc   (NASDAQ: JANX)


Janux Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Janux Therapeutics Inc's ROI in the second quarter of 2026?
Janux Therapeutics Inc recorded a cumulative net loss of $-103 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -10.55%.

Within the Healthcare sector 256 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3147, from total ROI ranking in the first quarter of 2026 at 3657.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 3.3 % 15.1 % 30.44 % 69.97 % 79.51 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 948 969 977 997 1,011
Return On Investment (TTM) -10.55 % -11.58 % -11.31 % -9.98 % -11.22 %
JANX's Overall Ranking # 3147 # 3657 # 3178 # 3228 # 3155
Seq. Investment Change TTM -1.6 % -1.59 % -1.65 % 8.47 % 9.63 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -103 -114 -114 -102 -106

JANX Company Profile >> Back to JANX Roi Comparisons >> See Annual JANX Return On Investment



Return On Investment JANX's Ranking
Within: No.
Industry # 88
Sector # 257
Overall # 3147

Return On Investment Statistics
High Average Low
-3.6 %
-11.57 %
-19.81 %
(Mar 31 2022)   (Jun 30 2023)







Financial Statements
Janux Therapeutics Inc's II. Quarter Investments $ 948 Millions JANX's Balance sheet
Janux Therapeutics Inc's II. Quarter Income $ -22 Millions Quarterly JANX's Income Statement
JANX's Income by Division See JANX's Income by Division


JANX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 977 1,044 367 348 367
Y / Y Investment Growth -6.46 % 184.19 % 5.72 % -5.32 % -
Net Income in Millions -114 -69 -58 -63 -33
Y / Y Net Income Growth - - - - -
Annual Return On Investment -11.64 % -6.61 % -15.87 % -18.15 % -8.9 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
JANX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for JANX's Competitors
Subscribers only: Roi for Janux Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for JANX's Customers

Other Ratios
JANX's Roa JANX's Inventory Turnover Ratio JANX's Growth Rates JANX's Dividend Statistics
JANX's Profitability Ratios JANX's Asset Turnover Ratio JANX's Dividend Growth
JANX's Roe JANX's Valuation Ratios JANX's Financial Strength Ratios JANX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T01:19:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.